FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W938477319> ?p ?o ?g. }

• W938477319 abstract "Cutaneous larva migrans merupakan infestasi dan migrasi larva cacing di dalam kulit. Cutaneous larva migrans masih sering didapatkan di negara tropis termasuk Indonesia. Data kunjungan di Poliklinik Bagian Penyakit Kulit dan Kelamin RS. Dr. Sardjito cutaneous larva migrans selalu ada setiap tahun. Albendazol oral merupakan pengobatan cutaneous larva migrans yang banyak digunakan saat ini, namun penggunaan per oral memiliki bioavailabilitas yang rendah disebabkan karena absorpsi didalam usus < 5%. Hal ini nampaknya penggunaan albendazol per oral tidak praktis karena larva hanya di epidermis. Tujuan penelitian ini adalah untuk membandingkan efektivitas salep albendazol 2% dengan tablet albendazol. Disain penelitian adalah double blind randomized controlled trial-paralel design. Subyek penelitian adalah penderita cutaneous larva migrans ≤ 1 minggu yang datang ke Poliklinik RS. DR. Sardjito, usia 7-50 tahun, terdapat gatal, eritem dan lorong. Semua subyek yang memenuhi kriteria penelitian diberi salep albendazol 2% atau albendazo tablet. Penilaian klinis dilakukan pada hari ke 3, ke 5 dan hari ke 7. Luaran hasil pengobatan yaitu kesembuhan diantara dua kelompok tersebut di uji dengan chi-square test. Manfaat yang diharapkan pada penelitian ini, bagi perkembangan dermatologi dapat memberikan sumbangan bukti ilmiah tentang pengobatan cutaneous larva migrans. Bagi dokter dan petugas kesehatan dapat digunakan sebagai alternatif pengobatan cutaneous larva migrans. Bagi masyarakat umum dapat memperoleh pengobatan cutaneous larva migrans dengan pengobatan yang lebih murah dan lebih aman.Cutaneous larva migrnas is an infestation and migration of larvae worm in the skin. This disease is still frequent in tropical countries including Indonesia. Based on data from dermatology outpatient clinic of DR. Sardjito Hospital, cutaneous larva migrans is consistenly found in whole year. Oral albendazole is the drug that has been used widely recently, although it has low bioavaibility due to its absorbtion in intestine is less than 5%. It seems that the oral albendazole is not effective because the larvae only in epidermis layer. Aim of this study is to compare the effectiveness of albendazole ointment 2% and albendazole tablet. This study is a double blind randomized controlled trial paralell design. Subyek are patients with cutaneous larva migrans at dermatovenerology outpatient clinic of DR. Sardjito Hospital, age 7-50 year old, clinical finding: itchy, erythema, and burrow. All of subyek will be given blindly either albendazole oint 2% or tablet. Evaluation will be done in the third, fifth and seventh day. The effectiveness or cure rate will be compared among two groups by using chi-square test. The result of this study is expected to provide the evidence for dermatology development to treat cutaneous larva migrans. For doctor and health care worker, these study is to give an alternative treatment for cutaneous larva migrant. For public, these study is to serve cheaper and safer treatment for cutaneous larva migrans" @default.
• W938477319 created "2016-06-24" @default.
• W938477319 creator A5054809482 @default.
• W938477319 creator A5087628532 @default.
• W938477319 date "2004-01-01" @default.
• W938477319 modified "2023-09-24" @default.
• W938477319 title "Efektivitas salep Albendazol 2 persen dibanding tablet Albendazol pada pengobatan Cutaneous Larva Migrans" @default.
• W938477319 hasPublicationYear "2004" @default.
• W938477319 type Work @default.
• W938477319 sameAs 938477319 @default.
• W938477319 citedByCount "0" @default.
• W938477319 crossrefType "journal-article" @default.
• W938477319 hasAuthorship W938477319A5054809482 @default.
• W938477319 hasAuthorship W938477319A5087628532 @default.
• W938477319 hasConcept C142724271 @default.
• W938477319 hasConcept C16005928 @default.
• W938477319 hasConcept C173758957 @default.
• W938477319 hasConcept C2776851587 @default.
• W938477319 hasConcept C2779726973 @default.
• W938477319 hasConcept C2911108036 @default.
• W938477319 hasConcept C59822182 @default.
• W938477319 hasConcept C71924100 @default.
• W938477319 hasConcept C86803240 @default.
• W938477319 hasConceptScore W938477319C142724271 @default.
• W938477319 hasConceptScore W938477319C16005928 @default.
• W938477319 hasConceptScore W938477319C173758957 @default.
• W938477319 hasConceptScore W938477319C2776851587 @default.
• W938477319 hasConceptScore W938477319C2779726973 @default.
• W938477319 hasConceptScore W938477319C2911108036 @default.
• W938477319 hasConceptScore W938477319C59822182 @default.
• W938477319 hasConceptScore W938477319C71924100 @default.
• W938477319 hasConceptScore W938477319C86803240 @default.
• W938477319 hasLocation W9384773191 @default.
• W938477319 hasOpenAccess W938477319 @default.
• W938477319 hasPrimaryLocation W9384773191 @default.
• W938477319 isParatext "false" @default.
• W938477319 isRetracted "false" @default.
• W938477319 magId "938477319" @default.
• W938477319 workType "article" @default.